Novadip Biosciences
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $43M
Investors
- 10
About Novadip Biosciences
, a spin-off company from Université Catholique de Louvain and St. Luc University Hospital, operates as a clinical-stage biopharmaceutical company that designs and develops a new class of regenerative tissue products to accelerate the healing of large bone defects and injuries.A. The company is creating an allogeneic product called NVD-X3 that uses a matrix containing a number of bioactive factors to promote quick tissue healing. Additionally, the company is working on NVD-003, an autologous therapy derived from ASCs, as a potential stand-alone treatment for patients with congenital pseudoarthrosis of the tibia and other uncommon pediatric bone conditions in order to preserve limbs and restore mobility.
Who invested in Novadip Biosciences
10 investors across 3 rounds
See all investors in Novadip Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novadip Biosciences
Who invested in Novadip Biosciences?
Novadip Biosciences has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novadip Biosciences raised?
Novadip Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Novadip Biosciences last raise money?
Novadip Biosciences's most recent round on record is a Series B, in Feb 2022.
What does Novadip Biosciences do?
, a spin-off company from Université Catholique de Louvain and St.
Where is Novadip Biosciences headquartered?
Novadip Biosciences is headquartered in Mont-Saint-Guibert, Belgium.
Which VCs invest in companies like Novadip Biosciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Novadip Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Novadip Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.